| 摘要 |
PROBLEM TO BE SOLVED: To provide novel apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents containing novel flavonol-sinapic acid reaction products exhibiting ApoB100 antisecretory action as an active ingredient.SOLUTION: Apolipoprotein B (ApoB100) secretion inhibitors, dyslipidemia preventive/therapeutic agents, hypercholesterolemia preventive/therapeutic agents and arteriosclerosis preventive agents contain one or more compounds selected from the group consisting of flavonol-sinapic acid reaction products shown by Figure 1 and their pharmacologically acceptable salts. |
